ArticleDiagnostics (Basel, Switzerland)2017

Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy.

Murali Kesavan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.